BABA
Alibaba Group Holding Limited
BABA has the edge over THCH overall, supported by lower modeled downside and stronger fundamentals.
THCH
TH International Limited
THCH offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
THCH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
THCH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
THCH PE Valuation
THCH has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over THCH on the outlook, with more favorable earnings and revenue expectations.
THCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect THCH's earnings, revenue and profitability to hold roughly steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over THCH on earnings quality, reporting a profit while its opponent remains loss making.
THCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.33 | -$0.70 |
| Q1 2026 | -$2.23 | -$0.73 |
| Q4 2025 | -$1.99 | -$0.08 |
| Q3 2025 | -$1.56 | +$1.19 |
| Q2 2025 | -$1.63 | +$1.47 |
| Q1 2025 | -$1.50 | +$2.51 |
| Q4 2024 | -$1.91 | +$2.62 |
| Q3 2024 | -$2.75 | +$2.00 |
THCH is still losing money, but far less than before: $2.33 per share over the past year, against $5.40 at its worst in mid-2023.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over THCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over THCH on profitability, with a higher operating margin.
THCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.9M | -22% |
| Q1 2026 | $38.3M | -15% |
| Q4 2025 | $45.7M | -8.5% |
| Q3 2025 | $53.7M | -0.4% |
| Q2 2025 | $52.4M | -4.9% |
| Q1 2025 | $45.1M | -9.5% |
| Q4 2024 | $49.9M | -15% |
| Q3 2024 | $54M | -17% |
THCH's revenue has slid since its 2023 peak: $41M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -20% | -9.2 points |
| Q1 2026 | -26% | -2.2 points |
| Q4 2025 | -28% | +2.1 points |
| Q3 2025 | -15% | -4.6 points |
| Q2 2025 | -11% | +4 points |
| Q1 2025 | -24% | +13 points |
| Q4 2024 | -30% | +29 points |
| Q3 2024 | -11% | +23 points |
THCH's operating margin was −20% last quarter, down 9.2 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
THCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.1M | +$5.3M |
| Q1 2026 | -$3.5M | -$3.5M |
| Q4 2025 | -$11.3M | -$6.5M |
| Q3 2025 | -$257.1K | +$1.7M |
| Q2 2025 | -$176.3K | -104% |
| Q1 2025 | -$32.9K | +$4M |
| Q4 2024 | -$4.7M | +$51.2M |
| Q3 2024 | -$2M | +$2.6M |
THCH has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
THCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -4.3K shares |
| 3 years | +6.7% | +2M shares |
| 5 years | +21% | +5.6M shares |
| Available history | +21% | +5.6M shares |
THCH has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
THCH hasn't bought back shares in the past year.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
THCH Net Leverage
THCH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
THCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.1 | Neutral |
THCH's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
THCH PE vs Consumer Cyclical Sector
THCH has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
THCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 6% above |
| 20 week MA | $1.40 | 11% below |
| 50 week MA | $1.79 | 31% below |
| 100 week MA | $2.32 | 47% below |
| 200 week MA | $6.07 | 80% below |
THCH has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over THCH on returns for 2026, with the stronger performance.
THCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.1 | $48.9 | -0.4% |
| 2022 | $48.9 | $15.7 | -68% |
| 2023 | $15.7 | $8.75 | -44% |
| 2024 | $8.75 | $3.73 | -57% |
| 2025 | $3.73 | $2.19 | -41% |
| 2026 YTD | $2.19 | $1.24 | -43% |
THCH has finished every year since 2021 lower, and it's down 43% so far in 2026.